Cartesian Therapeutics Inc (RNAC)
Other Income/Expenses (Net)
-$62.43M
TTM · Period ending: · USD
RNAC Other Income/Expenses (Net)
Latest reported-$62.43Mperiod ending
Latest reported-$62.43Mperiod ending
RNAC TTM Other Income/Expenses (Net) ($130.00K → -$62.43M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
RNAC other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -62,425,000 | |
| -69,652,000 | |
| -52,790,000 | |
| 43,805,000 | |
| 52,033,000 | |
| 14,415,000 | |
| -33,240,000 | |
| -210,331,000 | |
| -199,660,000 | |
| -192,488,000 | |
| -152,294,000 | |
| 22,133,000 | |
| 11,455,000 | |
| -1,055,000 | |
| 20,232,000 | |
| 14,430,000 | |
| 20,948,000 | |
| 30,320,000 | |
| -5,124,000 | |
| -20,971,000 | |
| -16,869,000 | |
| -28,696,000 | |
| -12,055,000 | |
| -6,825,000 | |
| -11,030,000 | |
| -3,475,000 | |
| -2,895,000 | |
| -729,000 | |
| -589,000 | |
| -457,000 | |
| -314,000 | |
| -429,000 | |
| -1,191,000 | |
| -1,260,000 | |
| -1,537,000 | |
| -1,493,000 | |
| -931,000 | |
| -1,357,000 | |
| -1,540,000 | |
| -1,059,000 | |
| -453,000 | |
| -482,000 | |
| 130,000 |